African swine fever virus chimeric protein, vaccine composition, preparation method and use thereof
AssigneePulike Biological Engineering, Inc.
InventorsKegong Tian, Wenqiang Pang, Xuke Zhang
Life of this patent
Estimating the term…
Abstract
Provided is an African swine fever virus chimeric protein. The chimeric protein comprises: (1) an African swine fever virus p72 domain I; (2) an African swine fever virus p72 domain II; (3) an African swine fever virus p72 domain III; and (4) an African swine fever virus antigenic protein. By using African swine fever virus p72 protein as a skeleton, the chimeric protein provided in the present invention will exhibit antigenic epitopes of African swine fever virus antigenic proteins p54, p30, CD2v, and p12, achieve a good immune effect, and can produce significant humoral and cell-mediated immune response.
Claims14
An African swine fever virus chimeric protein comprising:
- a. African swine fever virus p72 domain I, with an amino acid sequence as shown in SEQ ID NO.2;
- b. African swine fever virus p72 domain II, with an amino acid sequence as shown in SEQ ID NO.3;
- c. African swine fever virus p72 domain III, with an amino acid sequence as shown in SEQ ID NO. 4;
- and
- d. African swine fever virus antigenic protein;
- e. the African swine fever virus p72 domain I is located at the N-terminus of the chimeric protein, the African swine fever virus p72 domain III is located at the C-terminus of the chimeric protein, and the African swine fever virus p72 domain II is located between the domain I and the domain III, the African swine fever virus antigenic protein is located between the domain I and the domain II or between the domain II and the domain III;
- f. the African swine fever virus antigenic protein is one fragment of p54, p30, CD2v and p12 proteins or one of the fragments as shown in SEQ ID NOs. 38-58;
- g. the fragment of p54 protein is selected from any one of SEQ ID NOs. 5, 6, 7, 8, 9, 10, 11, and 12;
- the fragment of p30 protein is selected from any one of SEQ ID NOs. 13, 14, 15, 16, 17, 18, and 19;
- the fragment of CD2v protein is selected from any one of SEQ ID NOs. 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 and 30;
- and
- the fragment of p12 protein is selected from any one of SEQ ID NOs. 31, 32, 33, 34, 35, 36, and 37.
Dependencies are inferred from the claim text.